PCL, Inc. (KOSDAQ:241820)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Vitro Diagnostics-Related Business	1.25B	8.43B	37.22B	46.15B	53.68B
Total	1.25B	8.43B	37.22B	46.15B	53.68B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
South Korea	1.17B	2.92B	28.33B	599.06M	3.91B
Overseas	-	-	-	45.55B	49.77B
Asia	19.75M	3.87B	2.68B	-	-
Other	34.09M	137.84M	1.17B	-	-
Europe	-	1.48B	5.04B	-	-
Total	1.22B	8.41B	37.22B	46.15B	53.68B

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error